MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-TS-09-0030790
Giyaan Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹39.31 Cr
▲ 16% YoY
Net profit · FY 2024
₹1.2 Cr
Net margin 3%
EBITDA · FY 2024
₹5.22 Cr
EBITDA margin 13.3%
Authorised capital
₹3.2 Cr
Registered with MCA
Paid-up capital
₹3.2 Cr
Issued & subscribed
Open charges
₹27.5 Cr
Satisfied ₹36.32 Cr
Company age
34 yrs
Est. 1992
Employees · EPFO
96
Provident fund records
About Giyaan Pharma Private Limited
Data last updated:
Giyaan Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 December 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG1992PTC015124. Its GSTIN is 37AACCM3033G1ZS (Andhra Pradesh). The company holds 4 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹3.2 Cr and a paid-up capital of ₹3.2 Cr. It was formerly known as M.K.Pharma Private Limited and M.K. Organics Private Limited. It is led by directors including Prasada Reddy Kambham (Managing Director) and Punugoti Sasidhar Reddy (Whole-Time Director).
Its last annual general meeting (AGM) was held on 27 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹39.31 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹1.2 Cr (net margin 3%) and EBITDA of ₹5.22 Cr (EBITDA margin 13.3%). Revenue has grown at a compounded annual rate (CAGR) of 62% over three years and 160% over five years.
The company has about 96 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Giyaan Pharma. As per MCA filings, the company has open charges of ₹27.5 Cr and satisfied charges of ₹36.32 Cr on record. Court records list 5 cases involving the company, including 3 filed by the company and 2 filed against it; 2 cases are pending. The company has 6 deals on record (4 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹1.2 Cr; the latest was in July 2019. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 2 smaller; the largest is Zenith Enzymatic Drugs Private Limited with revenue of ₹39.93 Cr. The company has 8 MSME Form 1 returns on record between 2019 and 2022, listing 108 overdue payments to 5 micro and small suppliers.
Giyaan Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0030790). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website giyaanpharma.com.
Company details
CIN U24100TG1992PTC015124
Registration Number 015124
Incorporation Date 14 December 1992
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-09-0030790
Name history
Giyaan Pharma has undergone 2 name changes throughout its history. The company was previously known as M.K.Pharma Private Limited, and M.K. Organics Private Limited. The current legal name is Giyaan Pharma Private Limited.
| Company Name | Status |
|---|---|
| Giyaan Pharma Private Limited | Current |
| M.K.Pharma Private Limited | Previous |
| M.K. Organics Private Limited | Previous |
CIN history
Giyaan Pharma has one previous CIN (Corporate Identification Number): U24100AP1992PTC015124. The current CIN is U24100TG1992PTC015124, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG1992PTC015124 | Current |
| U24100AP1992PTC015124 | Previous |
Key People
Prasada Reddy Kambham Managing Director Punugoti Sasidhar Reddy Whole-Time Director Spoorthi Kambam Director Recognitions & Rankings of Giyaan Pharma
Contact details
Giyaan Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is giyaanpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1st Floor The Mahaveer Watermark, Plot No 11 Sy No 9 Hitech City, Hyderabad, Telangana, India – 500084
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Giyaan Pharma Private Limited, buy the company report.
Comprehensive company report
Giyaan Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Giyaan Pharma operates one associated brand: Giyaan Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations such as tablets, capsules, and dry syrups are manufactured by Giyaan Pharma for domestic and international markets. | giyaanpharma.com |
Business activity
The main business activity of Giyaan Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Giyaan Pharma Private Limited, buy the company report.
Financials of Giyaan Pharma Private Limited
FY 2024 filings availableGiyaan Pharma Private Limited reported revenue of ₹39.31 Cr (up 16% YoY) for FY 2024.
Revenue · FY 2024
₹39.31 Cr ▲ 16%
Net profit · FY 2024
₹1.2 Cr margin 3%
EBITDA · FY 2024
₹5.22 Cr margin 13.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 62%
5 years · compounded
▲ 160%
EBITDA CAGR growth
1 year
▼ 5%
3 years · compounded
▲ 114%
5 years · compounded
▲ 49%
Revenue has grown at a compounded annual rate (CAGR) of 160% over five years, including 16% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹39.31 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.22 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.2 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.3% | ||||
| Net Profit Margin | 3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Giyaan Pharma Private Limited, buy the company report.
Board of directors of Giyaan Pharma Private Limited
Giyaan Pharma has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Punugoti Sasidhar Reddy Also directs: Tini Pharma Private Limited, Tini Laboratories Pvt Ltd | Whole-Time Director | 25 Jan 2001 | 25 Years 9 Months | Current |
| Prasada Reddy Kambham | Managing Director | 10 Jul 2017 | 9 Years 3 Months | Current |
| Spoorthi Kambam Also directs: Rajpet Energy LLP, Swarnaakshu Green Power LLP, Swarnaakshu Solar Power Private Limited and 5 more | Director | 10 Jul 2017 | 9 Years 3 Months | Current |
Peer comparison
Giyaan Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zenith Enzymatic Drugs Private Limited | ₹39.93 Cr (FY 2024) | 6.0% | Pune, Maharashtra, India | |||
| Vanelloid Private Limited | ₹39.6 Cr (FY 2024) | 11.0% | Ludhiana, Punjab, India | |||
| MMC Health Care Limited | ₹39.6 Cr (FY 2024) | -17.0% | Chennai, Tamil Nadu, India | |||
| Strides Emerging Markets Limited | ₹39.32 Cr (FY 2020) | 735.0% | Bangalore, Karnataka, India | |||
| Giyaan Pharma Private Limitedthis company | ₹39.31 Cr (FY 2024) | ₹1.2 Cr | 3% | 16.0% | 96 | Hyderabad, Telangana, India |
| Embiotic Laboratories Private Limited | ₹39.29 Cr (FY 2025) | 3.0% | Bangalore, Karnataka, India | |||
| Forma Chem Pvt Ltd | ₹39.25 Cr (FY 2025) | -46.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Giyaan Pharma Private Limited, buy the company report.
Auditor
Giyaan Pharma Private Limited is audited by K.NAGARAJU & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K.NAGARAJU & ASSOCIATES | FY 2024 | 002270S |
Shareholding
The shareholding of Giyaan Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Giyaan Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹27.5 Cr
Satisfied charges
₹36.32 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Jul 2023 | 100753202 | Others | ₹27.5 Cr | Open | |
| 13 Jul 2020 | 100348120 | Others | ₹1.95 Cr | Satisfied | |
| 13 Jul 2018 | 100210522 | Others | ₹10.92 Cr | Satisfied | |
| 06 Nov 2017 | 100132824 | Others | ₹19.1 Cr | Satisfied | |
| 21 Jun 2010 | 10233048 | Tamilnad Mercantile Bank Limited | ₹6.8 Lakh | Satisfied |
To see the full charge records of Giyaan Pharma Private Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Giyaan Pharma Private Limited has 6 deals on record (4 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹1.2 Cr; the latest was in July 2019.
Total deals
6
Secondary share transfers
4
Rights issue
1
Funding round
1
Disclosed funding
₹1.2 Cr
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2019 | Funding round | ₹1.2 Cr | Investors: 3 individuals |
| Oct 2017 | Rights issue | ₹1.23 Cr | Investors: 4 individuals |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
To see the full deal history of Giyaan Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Giyaan Pharma Private Limited has 5 court cases on record: 3 filed by Giyaan Pharma, 2 filed against it. 2 cases are pending and 3 are disposed.
Total cases
5
Filed by the company
3
Filed against the company
2
Pending
2
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 2 | 2 |
Cases on record (4 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed by the company against Habitare Pharma Pvt Ltd and 2 others | Pending |
| District court, Chittoor, Andhra Pradesh | Civil suit | Filed by the company against M/Smolekule India Private Limited Represented by Its Directors and 2 others | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed against the company by Standard Chartered Bank Th. Vinay Patil | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed against the company by Standard Chartered Bank Th. Mr. Atul Gopal Pathak | Disposed |
To see the full case history of Giyaan Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Giyaan Pharma Private Limited has 8 MSME Form 1 returns on record between 2019 and 2022, listing 108 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
To see the full MSME payment records of Giyaan Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Giyaan Pharma Private Limited has a workforce of 96 employees on its EPFO records as of Mar 08, 2025, across 1 active EPFO establishment.
Employee count
96
Active EPFO establishments
1
Employee growth
14.29%
GST
Giyaan Pharma has 4 GST registrations: 1 active and 3 cancelled or inactive.
Total GSTINs
4
Active
1
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AACCM3033G1ZS | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Giyaan Pharma Private Limited, buy the company report.
Recent activity
Giyaan Pharma Private Limited has 9 board changes on record since 2001: 3 appointments and 6 cessations. The latest: Prasada Reddy Kambham ceased to be Director on 17 Jun 2019.
AGM
Giyaan Pharma Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records.
Charges
A charge registered on 13 Jul 2018 via Charge ID 100210522 with Others was fully satisfied on 14 Jun 2024.
Charges
A charge with Others of Rs. 27.50 Cr registered on 19 Jul 2023 with Charge ID 100753202 was modified on 28 May 2024.
Filing
Giyaan Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge registered on 13 Jul 2020 via Charge ID 100348120 with Others was fully satisfied on 27 Sep 2023.
Charges
A charge registered on 06 Nov 2017 via Charge ID 100132824 with Others was fully satisfied on 27 Sep 2023.
Charges
A charge with Others amounted to Rs. 27.50 Cr with Charge ID 100753202 was registered on 19 Jul 2023.
Charges
A charge with Others of Rs. 10.92 Cr registered on 13 Jul 2018 with Charge ID 100210522 was modified on 25 Aug 2021.
Charges
A charge with Others of Rs. 1.95 Cr registered on 13 Jul 2020 with Charge ID 100348120 was modified on 25 Aug 2020.
Charges
A charge with Others amounted to Rs. 1.95 Cr with Charge ID 100348120 was registered on 13 Jul 2020.
Ceased
Prasada Reddy Kambham ceased to be Director.
Ceased
Punugoti Sasidhar Reddy ceased to be Managing Director.
21 earlier events are in the company report.
Frequently asked questions
Giyaan Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 December 1992 (34+ years old) and is registered under CIN U24100TG1992PTC015124.
Giyaan Pharma has 3 current directors:
- Prasada Reddy Kambham - Managing Director
- Punugoti Sasidhar Reddy - Whole-Time Director
- Spoorthi Kambam - Director
The latest financial statements of Giyaan Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 27 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Giyaan Pharma is 37AACCM3033G1ZS, registered in Andhra Pradesh. The company has 4 GST registrations in all, of which 1 is active and 3 are cancelled or inactive.
The CIN (Corporate Identification Number) of Giyaan Pharma is U24100TG1992PTC015124. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Giyaan Pharma has 5 court cases on record: 3 filed by the company and 2 filed against it. 2 are pending.
Giyaan Pharma was incorporated on 14 December 1992, making it 34+ years old. It is registered with the Registrar of Companies, Hyderabad.
Giyaan Pharma has 6 deals on record (4 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹1.2 Cr; the latest was in July 2019.
The peers of Giyaan Pharma by revenue are Zenith Enzymatic Drugs Private Limited, Vanelloid Private Limited, MMC Health Care Limited, Strides Emerging Markets Limited, Embiotic Laboratories Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Prasada Reddy Kambham ceased to be Director on 17 Jun 2019. Punugoti Sasidhar Reddy ceased to be Managing Director on 17 Jun 2019. Spoorthi Kambam ceased to be Additional Director on 30 Sep 2017. Giyaan Pharma has 9 board changes on record in total.
Yes, Giyaan Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-09-0030790).
Giyaan Pharma has 8 MSME Form 1 returns on record between 2019 and 2022, listing 108 overdue payments to 5 micro and small suppliers. The latest return was filed on 07 Feb 2024.